Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
BMC Bioinformatics|August 16, 2022
Identifying essential proteins from protein-protein interaction networks based on influence maximizationWeixia Xu, Yunfeng Dong, Jihong Guan, et al.BMC Bioinformatics|October 9, 2021
Protein-protein interaction prediction based on ordinal regression and recurrent convolutional neural networksWeixia Xu, Yangyun Gao, Yang Wang, et al.Bioinformatics (Oxford, England)|May 6, 2024
Molecular property prediction based on graph structure learningBangyi Zhao, Weixia Xu, Jihong Guan, et al.Cancer Letters|October 21, 2019
Macroporous organosilicon nanocomposites co-deliver Bcl2-converting peptide and chemotherapeutic agent for synergistic treatment against multidrug resistant cancerJingjing Xie, Weixia Xu, Yuehuang Wu, et al.Journal of Colloid and Interface Science|May 23, 2018
Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cellsWeixia Xu, Pengjin Ge, Boning Niu, et al.International Journal of Pharmaceutics|November 6, 2018
Dendrimer-like mesoporous silica nanospheres with suitable surface functionality to combat the multidrug resistanceWeixia Xu, Xiaofeng Gao, Pengjin Ge, et al.Materials Science & Engineering. C, Materials for Biological Applications|January 12, 2020
Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatmentYuehuang Wu, Pengjin Ge, Weixia Xu, et al.IEEE Transactions on Visualization and Computer Graphics|August 24, 2019
A Natural-language-based Visual Query Approach of Uncertain Human TrajectoriesZhaosong Huang, Ye Zhao, Wei Chen, et al.Colloids and Surfaces. B, Biointerfaces|June 20, 2021
Impact of macroporous silica nanoparticles at sub-50nm on bio-behaviors and biosafety in drug-resistant cancer modelsWeixia Xu, Min Zhou, Zhihan Guo, et al.Acta Pharmaceutica Sinica. B|February 23, 2023
All-stage targeted therapy for the brain metastasis from triple-negative breast cancerZimiao Luo, Sunyi Wu, Jianfen Zhou, et al.Pageof 2